Technical Analysis for CELC - Celcuity Inc.

Grade Last Price % Change Price Change
B 26.03 -3.27% -0.88
CELC closed up 3.54 percent on Friday, May 14, 2021, on 5 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical CELC trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -3.27%
Bollinger Band Squeeze Range Contraction -3.27%
BB Squeeze Started Range Contraction -3.27%
Inside Day Range Contraction -3.27%
Fell Below 20 DMA Bearish 0.15%
Crossed Above 20 DMA Bullish -3.56%
New Uptrend Bullish -3.56%
New Downtrend Bearish 0.42%
Hammer Candlestick Bullish 0.42%
Lower Bollinger Band Touch Weakness 0.42%
Older End-of-Day Signals for CELC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 16 minutes ago
Down 3% 16 minutes ago
10 DMA Support about 2 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Celcuity Inc. Description

Celcuity, Inc. is a United States-based early stage biotechnology company. The Company develops tests that functionally analyze diseased live cells. The Company has developed CELx Pathway Profile technology, which combines advancements in primary tissue research with a method of measuring a targeted therapy's functional pathway effect on live and diseased patient cells. The Company offers functional cellular analysis platform that assesses the functionality of the disease-related signaling pathways of patient's diseased cells ex vivo and determines whether a drug therapy has the effect on diseased cells. The Company's CELx test is designed to determine whether a pathway is functional to therapeutic intervention without regard to the exact mechanism a patient's tumor may have developed to resist the therapeutic effect. The Company’s diagnostic approach helps to identify cancer subtypes.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Biology Stem Cells Cell Biology Targeted Therapy Signal Transduction Cell Signaling Systems Biology Drug Therapy Patient's Tumor

Is CELC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.4172
52 Week Low 5.0
Average Volume 473,525
200-Day Moving Average 11.92
50-Day Moving Average 20.55
20-Day Moving Average 26.57
10-Day Moving Average 26.79
Average True Range 1.91
ADX 33.45
+DI 23.26
-DI 19.54
Chandelier Exit (Long, 3 ATRs ) 24.70
Chandelier Exit (Short, 3 ATRs ) 28.55
Upper Bollinger Band 29.50
Lower Bollinger Band 23.65
Percent B (%b) 0.56
BandWidth 22.02
MACD Line 1.52
MACD Signal Line 2.04
MACD Histogram -0.5171
Fundamentals Value
Market Cap 277.09 Million
Num Shares 10.3 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -37.69
Price-to-Sales 0.00
Price-to-Book 7.44
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.02
Resistance 3 (R3) 28.95 28.17 28.67
Resistance 2 (R2) 28.17 27.63 28.21 28.55
Resistance 1 (R1) 27.54 27.30 27.86 27.61 28.43
Pivot Point 26.77 26.77 26.92 26.80 26.77
Support 1 (S1) 26.13 26.23 26.45 26.21 25.39
Support 2 (S2) 25.36 25.90 25.40 25.27
Support 3 (S3) 24.73 25.36 25.15
Support 4 (S4) 24.80